Joy M. Gary

A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

David M. Thomas, Dina Halai, Sean Davis, 2015, Cancer discovery.

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma

Jaime Rodriguez-Canales, Stephen M Hewitt, Catherine M Conway, 2013, Pigment cell & melanoma research.

Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy

B. Mock, J. Simmons, Shuling Zhang, 2015, Clinical Cancer Research.

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

Kecheng Zhang, W. Dubois, Jing Huang, 2017, Molecular Cancer Therapeutics.

Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis

R. M. Simpson, J. Testa, W. Dubois, 2020, Molecular Cancer Therapeutics.

cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma

R. M. Simpson, Yunlong He, W. Dubois, 2017, Stem cell reports.

B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses

R. M. Simpson, Ke Zhang, C. Snapper, 2013, The Journal of Immunology.

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation

Kecheng Zhang, W. Dubois, Jing Huang, 2017, Molecular Cancer Therapeutics.

B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses

Ke Zhang, C. Snapper, R. Casellas, 2013, The Journal of Immunology.